Decreased pregnane X receptor expression in children with active crohn's disease

Valentina Shakhnovich, Carrie Vyhlidal, Craig Friesen, Amber Hildreth, Vivekanand Singh, James Daniel, Gregory L. Kearns, J. Steven Leeder

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Expression of the pregnane X receptor (PXR) has been reported to be decreased in animal models of inflammatory bowel disease (IBD). To investigate the differential expression of PXR in children with Crohn's disease, a type of IBD, RNA was extracted from archived intestinal biopsies from 18 children with Crohn's disease (CD) and 12 age- and sex-matched controls (aged 7-17yrs). The aim of this investigation was to compare the relative mRNA expression of PXR, cytochrome p450 3A4 (CYP3A4), and villin 1 (VIL1) (a marker of epithelial cell integrity) in the inflamed terminal ileum (TI) versus noninflamed duodenum of children with CD. Relative expression was determined via reverse transcription real-time quantitative polymerase chain reaction, data normalized to glyceraldehyde 3-phosphate dehydrogenase, and differences in gene expression explored via paired t tests. PXR expression was decreased in the inflamed TI versus noninflamed duodenum (TI = 1.88 ± 0.89 versus duodenum = 2.5 ± 0.67; P < 0.001) in CD, but not controls (TI = 2.11 ± 0.41 versus duodenum = 2.26 ± 0.61; P = 0.52). CYP3A4 expression was decreased in CD (TI = -0.89 ± 3.11 versus duodenum = 1.90 ± 2.29; P < 0.05), but not controls (TI = 2.46 ± 0.51 versus duodenum = 2.60 ± 0.60; P = 0.61), as was VIL1 (CD TI = 3.80 ± 0.94 versus duodenum = 4.61 ± 0.52; P < 0.001; controls TI = 4.30 ± 0.35 versus duodenum = 4.47 ± 0.40; P = 0.29). PXR expression correlated with VIL1 (r = 0.78, P=0.01) and CYP3A4 (r = 0.52, P=0.01) expression. In conclusion, PXR, CYP3A4, and VIL1 expression was decreased only in the actively inflamed small intestinal tissue in children with CD. Our findings suggest that inflammation has the potential to influence expression of genes, and potentially intestinal proteins, important to drug disposition and response. The observed differential patterns of gene expression support further investigation of the role of PXR in the pathogenesis and/or treatment of pediatric Crohn's disease.

Original languageEnglish (US)
Pages (from-to)1066-1069
Number of pages4
JournalDrug Metabolism and Disposition
Volume44
Issue number7
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Ileum
Duodenum
Crohn Disease
Cytochrome P-450 CYP3A
Inflammatory Bowel Diseases
Gene Expression
Glyceraldehyde-3-Phosphate Dehydrogenases
pregnane X receptor
Reverse Transcription
Real-Time Polymerase Chain Reaction
Animal Models
Epithelial Cells
RNA
Inflammation
Biopsy
Messenger RNA
villin
Pharmaceutical Preparations
Proteins

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Shakhnovich, V., Vyhlidal, C., Friesen, C., Hildreth, A., Singh, V., Daniel, J., ... Leeder, J. S. (2016). Decreased pregnane X receptor expression in children with active crohn's disease. Drug Metabolism and Disposition, 44(7), 1066-1069. https://doi.org/10.1124/dmd.115.068742

Decreased pregnane X receptor expression in children with active crohn's disease. / Shakhnovich, Valentina; Vyhlidal, Carrie; Friesen, Craig; Hildreth, Amber; Singh, Vivekanand; Daniel, James; Kearns, Gregory L.; Leeder, J. Steven.

In: Drug Metabolism and Disposition, Vol. 44, No. 7, 01.07.2016, p. 1066-1069.

Research output: Contribution to journalArticle

Shakhnovich, V, Vyhlidal, C, Friesen, C, Hildreth, A, Singh, V, Daniel, J, Kearns, GL & Leeder, JS 2016, 'Decreased pregnane X receptor expression in children with active crohn's disease', Drug Metabolism and Disposition, vol. 44, no. 7, pp. 1066-1069. https://doi.org/10.1124/dmd.115.068742
Shakhnovich, Valentina ; Vyhlidal, Carrie ; Friesen, Craig ; Hildreth, Amber ; Singh, Vivekanand ; Daniel, James ; Kearns, Gregory L. ; Leeder, J. Steven. / Decreased pregnane X receptor expression in children with active crohn's disease. In: Drug Metabolism and Disposition. 2016 ; Vol. 44, No. 7. pp. 1066-1069.
@article{e4c0b1b5780d4f2788cc0c2fe8ce64ca,
title = "Decreased pregnane X receptor expression in children with active crohn's disease",
abstract = "Expression of the pregnane X receptor (PXR) has been reported to be decreased in animal models of inflammatory bowel disease (IBD). To investigate the differential expression of PXR in children with Crohn's disease, a type of IBD, RNA was extracted from archived intestinal biopsies from 18 children with Crohn's disease (CD) and 12 age- and sex-matched controls (aged 7-17yrs). The aim of this investigation was to compare the relative mRNA expression of PXR, cytochrome p450 3A4 (CYP3A4), and villin 1 (VIL1) (a marker of epithelial cell integrity) in the inflamed terminal ileum (TI) versus noninflamed duodenum of children with CD. Relative expression was determined via reverse transcription real-time quantitative polymerase chain reaction, data normalized to glyceraldehyde 3-phosphate dehydrogenase, and differences in gene expression explored via paired t tests. PXR expression was decreased in the inflamed TI versus noninflamed duodenum (TI = 1.88 ± 0.89 versus duodenum = 2.5 ± 0.67; P < 0.001) in CD, but not controls (TI = 2.11 ± 0.41 versus duodenum = 2.26 ± 0.61; P = 0.52). CYP3A4 expression was decreased in CD (TI = -0.89 ± 3.11 versus duodenum = 1.90 ± 2.29; P < 0.05), but not controls (TI = 2.46 ± 0.51 versus duodenum = 2.60 ± 0.60; P = 0.61), as was VIL1 (CD TI = 3.80 ± 0.94 versus duodenum = 4.61 ± 0.52; P < 0.001; controls TI = 4.30 ± 0.35 versus duodenum = 4.47 ± 0.40; P = 0.29). PXR expression correlated with VIL1 (r = 0.78, P=0.01) and CYP3A4 (r = 0.52, P=0.01) expression. In conclusion, PXR, CYP3A4, and VIL1 expression was decreased only in the actively inflamed small intestinal tissue in children with CD. Our findings suggest that inflammation has the potential to influence expression of genes, and potentially intestinal proteins, important to drug disposition and response. The observed differential patterns of gene expression support further investigation of the role of PXR in the pathogenesis and/or treatment of pediatric Crohn's disease.",
author = "Valentina Shakhnovich and Carrie Vyhlidal and Craig Friesen and Amber Hildreth and Vivekanand Singh and James Daniel and Kearns, {Gregory L.} and Leeder, {J. Steven}",
year = "2016",
month = "7",
day = "1",
doi = "10.1124/dmd.115.068742",
language = "English (US)",
volume = "44",
pages = "1066--1069",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "7",

}

TY - JOUR

T1 - Decreased pregnane X receptor expression in children with active crohn's disease

AU - Shakhnovich, Valentina

AU - Vyhlidal, Carrie

AU - Friesen, Craig

AU - Hildreth, Amber

AU - Singh, Vivekanand

AU - Daniel, James

AU - Kearns, Gregory L.

AU - Leeder, J. Steven

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Expression of the pregnane X receptor (PXR) has been reported to be decreased in animal models of inflammatory bowel disease (IBD). To investigate the differential expression of PXR in children with Crohn's disease, a type of IBD, RNA was extracted from archived intestinal biopsies from 18 children with Crohn's disease (CD) and 12 age- and sex-matched controls (aged 7-17yrs). The aim of this investigation was to compare the relative mRNA expression of PXR, cytochrome p450 3A4 (CYP3A4), and villin 1 (VIL1) (a marker of epithelial cell integrity) in the inflamed terminal ileum (TI) versus noninflamed duodenum of children with CD. Relative expression was determined via reverse transcription real-time quantitative polymerase chain reaction, data normalized to glyceraldehyde 3-phosphate dehydrogenase, and differences in gene expression explored via paired t tests. PXR expression was decreased in the inflamed TI versus noninflamed duodenum (TI = 1.88 ± 0.89 versus duodenum = 2.5 ± 0.67; P < 0.001) in CD, but not controls (TI = 2.11 ± 0.41 versus duodenum = 2.26 ± 0.61; P = 0.52). CYP3A4 expression was decreased in CD (TI = -0.89 ± 3.11 versus duodenum = 1.90 ± 2.29; P < 0.05), but not controls (TI = 2.46 ± 0.51 versus duodenum = 2.60 ± 0.60; P = 0.61), as was VIL1 (CD TI = 3.80 ± 0.94 versus duodenum = 4.61 ± 0.52; P < 0.001; controls TI = 4.30 ± 0.35 versus duodenum = 4.47 ± 0.40; P = 0.29). PXR expression correlated with VIL1 (r = 0.78, P=0.01) and CYP3A4 (r = 0.52, P=0.01) expression. In conclusion, PXR, CYP3A4, and VIL1 expression was decreased only in the actively inflamed small intestinal tissue in children with CD. Our findings suggest that inflammation has the potential to influence expression of genes, and potentially intestinal proteins, important to drug disposition and response. The observed differential patterns of gene expression support further investigation of the role of PXR in the pathogenesis and/or treatment of pediatric Crohn's disease.

AB - Expression of the pregnane X receptor (PXR) has been reported to be decreased in animal models of inflammatory bowel disease (IBD). To investigate the differential expression of PXR in children with Crohn's disease, a type of IBD, RNA was extracted from archived intestinal biopsies from 18 children with Crohn's disease (CD) and 12 age- and sex-matched controls (aged 7-17yrs). The aim of this investigation was to compare the relative mRNA expression of PXR, cytochrome p450 3A4 (CYP3A4), and villin 1 (VIL1) (a marker of epithelial cell integrity) in the inflamed terminal ileum (TI) versus noninflamed duodenum of children with CD. Relative expression was determined via reverse transcription real-time quantitative polymerase chain reaction, data normalized to glyceraldehyde 3-phosphate dehydrogenase, and differences in gene expression explored via paired t tests. PXR expression was decreased in the inflamed TI versus noninflamed duodenum (TI = 1.88 ± 0.89 versus duodenum = 2.5 ± 0.67; P < 0.001) in CD, but not controls (TI = 2.11 ± 0.41 versus duodenum = 2.26 ± 0.61; P = 0.52). CYP3A4 expression was decreased in CD (TI = -0.89 ± 3.11 versus duodenum = 1.90 ± 2.29; P < 0.05), but not controls (TI = 2.46 ± 0.51 versus duodenum = 2.60 ± 0.60; P = 0.61), as was VIL1 (CD TI = 3.80 ± 0.94 versus duodenum = 4.61 ± 0.52; P < 0.001; controls TI = 4.30 ± 0.35 versus duodenum = 4.47 ± 0.40; P = 0.29). PXR expression correlated with VIL1 (r = 0.78, P=0.01) and CYP3A4 (r = 0.52, P=0.01) expression. In conclusion, PXR, CYP3A4, and VIL1 expression was decreased only in the actively inflamed small intestinal tissue in children with CD. Our findings suggest that inflammation has the potential to influence expression of genes, and potentially intestinal proteins, important to drug disposition and response. The observed differential patterns of gene expression support further investigation of the role of PXR in the pathogenesis and/or treatment of pediatric Crohn's disease.

UR - http://www.scopus.com/inward/record.url?scp=84975123084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975123084&partnerID=8YFLogxK

U2 - 10.1124/dmd.115.068742

DO - 10.1124/dmd.115.068742

M3 - Article

C2 - 27013401

AN - SCOPUS:84975123084

VL - 44

SP - 1066

EP - 1069

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 7

ER -